However, the successful use of our phosphorylation-specific antibodies in immunohistocytochemistry allowed us to demonstrate the presence and pattern of PAX3-FOXO1 phosphorylation in primary tumor samples for the first time. Here, FOXO1 is linked to neoplasm.